Stocks · Health care · Pharmaceutical Preparations

COLLEGIUM PHARMACEUTICAL, INC

COLL Clue Score59
United States Fiscal year ends December CIK 0001267565 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
John Gordon Freund
15 May 2026
Director
Sold after exercise
4,127
$34.54
$142.55K
Garen G Bohlin
11 May 2026
Director
Sold after exercise
8,700
$37.18
$323.49K
Scott Dreyer
8 Dec 2025
EVP & Chief Commercial Officer
Sold after exercise
6,475
$48.66
$315.08K
Scott Dreyer
8 Dec 2025
EVP & Chief Commercial Officer
Sold after exercise
11,125
$47.89
$532.77K
John A. Fallon
12 Nov 2025
Director
Sold after exercise
34,853
$47.21
$1.65M
Scott Dreyer
18 Aug 2025
EVP & Chief Commercial Officer
Sold after exercise
16,389
$38.21
$626.17K
Gino Santini
15 Aug 2025
Director
Sold after exercise
5,405
$37.19
$201.02K
Scott Dreyer
13 Aug 2025
EVP & Chief Commercial Officer
Sold after exercise
4,861
$38.03
$184.88K
John Gordon Freund
9 Jun 2025
Director
Sold after exercise
6,601
$30.62
$202.15K
Shirley R. Kuhlmann
4 Mar 2025
EVP and General Counsel
Sold after exercise
40,000
$28.08
$1.12M
Shirley R. Kuhlmann
10 Jan 2025
EVP and General Counsel
Sold after exercise
6,100
$33.64
$205.22K
Shirley R. Kuhlmann
10 Jan 2025
EVP and General Counsel
Sold after exercise
21,400
$32.87
$703.41K
Scott Dreyer
24 May 2024
EVP & Chief Commercial Officer
Sold after exercise
56,807
$33.98
$1.93M
Scott Dreyer
23 May 2024
EVP & Chief Commercial Officer
Sold after exercise
51,209
$33.82
$1.73M
Garen G Bohlin
14 May 2024
Director
Sold after exercise
28,985
$32.30
$936.31K
Joseph Ciaffoni
21 Dec 2023
President and CEO
Sold after exercise
4,357
$30.38
$132.38K
Joseph Ciaffoni
20 Dec 2023
President and CEO
Sold after exercise
26,454
$30.40
$804.21K
Joseph Ciaffoni
19 Dec 2023
President and CEO
Sold after exercise
14,516
$30.03
$435.94K
Joseph Ciaffoni
18 Dec 2023
President and CEO
Sold after exercise
27,798
$30.04
$834.94K
Shirley R. Kuhlmann
27 Nov 2023
EVP and General Counsel
Sold after exercise
25,600
$25.78
$660.01K
Joseph Ciaffoni
13 Feb 2023
President and CEO
Sold after exercise
11,250
$26.88
$302.40K
Michael Thomas Heffernan
27 Dec 2022
Director
Sold after exercise
3,820
$24.16
$92.29K
Michael Thomas Heffernan
27 Dec 2022
Director
Sold after exercise
15,995
$23.63
$377.96K
Michael Thomas Heffernan
23 Dec 2022
Director
Sold after exercise
4,989
$23.00
$114.75K
Michael Thomas Heffernan
22 Dec 2022
Director
Sold after exercise
237
$23.00
$5.45K
Michael Thomas Heffernan
21 Dec 2022
Director
Sold after exercise
46,600
$23.11
$1.08M
Michael Thomas Heffernan
20 Dec 2022
Director
Sold after exercise
33,758
$23.08
$779.13K
Michael Thomas Heffernan
19 Dec 2022
Director
Sold after exercise
3,606
$23.04
$83.08K
Michael Thomas Heffernan
13 Dec 2022
Director
Sold after exercise
161,687
$22.16
$3.58M
Michael Thomas Heffernan
12 Dec 2022
Director
Sold after exercise
27,920
$22.01
$614.52K
Joseph Ciaffoni
1 Dec 2022
President and CEO
Sold after exercise
76,653
$22.47
$1.72M
Joseph Ciaffoni
28 Nov 2022
President and CEO
Sold after exercise
43
$22.00
$946.00
Joseph Ciaffoni
22 Nov 2022
President and CEO
Sold after exercise
65
$22.00
$1.43K
Joseph Ciaffoni
18 Nov 2022
President and CEO
Sold after exercise
1,989
$22.02
$43.80K
Joseph Ciaffoni
1 Jun 2021
President and CEO
Sold after exercise
10,829
$23.33
$252.64K
Joseph Ciaffoni
1 Jun 2021
President and CEO
Sold after exercise
5,376
$22.93
$123.27K
Joseph Ciaffoni
1 Mar 2021
President and CEO
Sold after exercise
9,809
$23.30
$228.55K
Joseph Ciaffoni
1 Mar 2021
President and CEO
Sold after exercise
54,959
$22.56
$1.24M
Alison B Fleming
7 Jan 2021
Chief Technology Officer
Sold after exercise
16,042
$22.00
$352.92K
Joseph Ciaffoni
1 Jun 2020
President and CEO
Sold after exercise
100
$22.08
$2.21K
Joseph Ciaffoni
1 Jun 2020
President and CEO
Sold after exercise
70,576
$21.53
$1.52M
Scott Dreyer
18 May 2020
EVP & Chief Commercial Officer
Sold after exercise
8,000
$24.00
$192.00K
Michael Thomas Heffernan
21 Jan 2020
Director
Sold after exercise
32,700
$22.69
$741.96K
Michael Thomas Heffernan
21 Jan 2020
Director
Sold after exercise
262,587
$21.84
$5.73M
Alison B Fleming
8 Nov 2019
Chief Technology Officer
Sold after exercise
25,000
$19.44
$486.00K
Joseph Ciaffoni
7 Nov 2019
President and CEO
Sold after exercise
31,226
$19.16
$598.29K
Joseph Ciaffoni
7 Nov 2019
President and CEO
Sold after exercise
33,595
$18.41
$618.48K
David Hirsch
29 Aug 2019
Director
Sold after exercise
22,106
$11.65
$257.53K
Joseph Ciaffoni
31 May 2018
Chief Operating Officer
Sold after exercise
5,617
$23.35
$131.16K
Joseph Ciaffoni
31 May 2018
Chief Operating Officer
Sold after exercise
59,204
$22.54
$1.33M
Alison B Fleming
19 Jan 2018
Chief Technology Officer
Sold after exercise
3,336
$23.00
$76.73K
Alison B Fleming
19 Jan 2018
Chief Technical Officer
Sold after exercise
1,449
$23.00
$33.33K
Alison B Fleming
19 Jan 2018
Chief Technical Officer
Sold after exercise
1,811
$23.00
$41.65K
Alison B Fleming
19 Jan 2018
Chief Technical Officer
Sold after exercise
64
$23.00
$1.47K
Alison B Fleming
12 Jan 2018
Chief Technical Officer
Sold after exercise
5,753
$21.00
$120.81K
Alison B Fleming
12 Jan 2018
Chief Technical Officer
Sold after exercise
1,747
$21.00
$36.69K
Alison B Fleming
10 Jan 2018
Chief Technology Officer
Sold after exercise
6,928
$19.07
$132.12K
Alison B Fleming
21 Nov 2017
Chief Technology Officer
Sold after exercise
572
$19.00
$10.87K
Alison B Fleming
17 Nov 2017
Chief Technology Officer
Sold after exercise
840
$17.00
$14.28K
Alison B Fleming
17 Nov 2017
Chief Technology Officer
Sold after exercise
1,239
$17.00
$21.06K
Alison B Fleming
17 Nov 2017
Chief Technology Officer
Sold after exercise
1,950
$17.00
$33.15K

What was left out

Form 4 filings counted 335
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 31
Sales straight out of an exercise 61
Sales at will 95
Transactions with no price 0
Shares from compensation/vesting 10,968,133
Sales filed before the plan box existed 82
History held since 13 May 2015